| Literature DB >> 1642396 |
S D Scoggin1, M Sivanandham, R G Sperry, M K Wallack.
Abstract
Vaccinia melanoma oncolysate is an investigative agent for active specific adjuvant immunotherapy. Viral oncolysate work in animals has led to application of this treatment in humans. Success of initial trials in treatment of melanoma has led to a phase III randomized, prospective, double-blind, multi-institutional trial, which is currently under way.Entities:
Mesh：
Substances：
Year: 1992 PMID： 1642396 DOI： 10.1097/00000637-199201000-00027
Source DB: PubMed Journal: Ann Plast Surg ISSN： 0148-7043 Impact factor: 1.539